ℹ️ Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. It may contain affiliate links. Always consult your physician or pharmacist before making changes to your medications. Full disclosure policy.

Eligibility Requirements

Income Limit
Up to 350% of Federal Poverty Level for free medication through GSK Patient Assistance Program
Insurance Requirements
Free medication for uninsured patients. Savings card for commercially insured patients.

Covered Medications

The following medications are covered by Trelegy Ellipta Savings (via GSK):

Trelegy Ellipta

How to Apply

Application Steps
  1. Speak with your healthcare provider about Trelegy Ellipta Savings (via GSK). Your doctor, nurse, or social worker can help determine if you qualify.
  2. Gather required documents: proof of income (tax return, pay stubs, or Social Security statement), valid prescription, and proof of U.S. residency.
  3. Submit your application online or by mail. Visit the program website below or call the program hotline for assistance.
  4. Wait for approval (typically 2 to 6 weeks). Once approved, medications will be shipped to your provider's office or a designated pharmacy.
Apply at Trelegy Ellipta Savings (via GSK) →

Check If You Qualify

Use our free Assistance Finder tool to check eligibility for Trelegy Ellipta Savings (via GSK) and other programs that may help reduce your medication costs.

Open Assistance Finder

Frequently Asked Questions

Can I get free Trelegy Ellipta?

Yes, uninsured patients with income at or below 350% FPL can receive free Trelegy through the GSK Patient Assistance Program. Your pulmonologist or prescriber must submit an application.

Is there a Trelegy copay card?

Yes, commercially insured patients can use the Trelegy savings card to reduce their copay to as low as $0 per month, with a maximum monthly benefit.

What is the difference between Trelegy and other COPD inhalers?

Trelegy combines three active ingredients (ICS + LAMA + LABA) in one inhaler, replacing the need for two separate inhalers. This simplifies the treatment regimen for COPD and asthma patients.